HR 1185 · 107th Congress 2001โ€“2003, ended

Global Access to HIV/AIDS Medicines Act of 2001

Latest action · Mar 22, 2001 Referred to the House Committee on International Relations.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 22, 2001
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Global Access to HIV/AIDS Medicines Act of 2001 - Prohibits funds appropriated to U.S. Federal agencies from being expended to seek, through negotiation or otherwise, the revocation or revision of intellectual property law or policy of a developing country that regulates HIV/AIDS pharmaceuticals or medical technologies, if such law or policy: (1) promotes access to HIV/AIDS pharmaceuticals or medical technologies to the country's population; and (2) provides adequate and effective intellectual property protection consistent with the Agreement on Trade-Related Aspects of Intellectual Property Rights of the Uruguay Round Agreements Act. Includes among such developing countries any sub-Saharan African country five percent or more of whose population is infected with HIV, or whose government has declared a national emergency with respect to HIV/AIDS.

Encourages such developing countries to implement policies designed to address the underlying causes of the HIV/AIDS crisis by making efforts to encourage practices that will prevent further transmission and infection and to stimulate development of the infrastructure necessary to deliver adequate health services, including policies that provide an incentive for public and private research on, and development of, vaccines and other medical innovations that will combat the HIV/AIDS epidemic, particularly in Africa.

Cosponsors 17

Members who signed on, in the order they did. Signatures ran from Mar 22, 2001 to Jun 28, 2001; 8 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
I-VTBernard SandersOriginalMar 22, 2001
D-MICarolyn C. KilpatrickOriginalMar 22, 2001
D-ILDanny K. DavisOriginalMar 22, 2001
D-VIDonna M. ChristensenOriginalMar 22, 2001
D-ILJanice D. SchakowskyOriginalMar 22, 2001
D-CAJuanita Millender-McDonaldOriginalMar 22, 2001
D-TXSheila Jackson LeeOriginalMar 22, 2001
D-OHStephanie Tubbs JonesOriginalMar 22, 2001
D-CAMaxine WatersApr 4, 2001
D-MDAlbert Russell WynnMay 2, 2001
D-SCJames E. ClyburnMay 2, 2001
D-MIJohn Conyers, Jr.May 2, 2001
D-INJulia CarsonMay 9, 2001
D-WITammy BaldwinMay 9, 2001
D-NYMajor R. OwensMay 23, 2001

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseForeign Affairs Committee
Referred Mar 22, 2001

Actions 2

Everything that happened, newest first.

  1. Mar 22, 2001Introduced in House
  2. Mar 22, 2001Referred to the House Committee on International Relations.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To prohibit through negotiation or otherwise the revocation or revision of any intellectual property or competition law or policy of a developing country, including any sub-Saharan African country, that regulates HIV/AIDS pharmaceuticals or medical technologies, and for other purposes.
Short Titles as Introduced
Global Access to HIV/AIDS Medicines Act of 2001

Subjects

Assigned by the Library of Congress. Policy area: International Affairs.

Text 1

Each version as it was printed, newest first.

  1. Mar 22, 2001Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.